# CYP2B6 Genetics and Drug Interactions in Healthy Volunteers

> **NCT02401256** · PHASE4 · COMPLETED · sponsor: **Indiana University** · enrollment: 70 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Efavirenz
- **DRUG:** Bupropion
- **DRUG:** Rosuvastatin
- **DRUG:** Montelukast

## Key facts

- **NCT ID:** NCT02401256
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2016-05
- **Final completion:** 2016-05-31
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2017-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02401256

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02401256, "CYP2B6 Genetics and Drug Interactions in Healthy Volunteers". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02401256. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*